Patent · US Active

Plymorphic forms of deferasirox (ICL670A)

US8946272B2 · kind B2 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Novartis AG · CH

Inventor

Michael Mutz · Glückstadt, DE

Key dates

Filing date	Apr 2, 2013
Grant date	Feb 3, 2015
Priority date	—
Expiry date	Apr 6, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to crystalline forms of 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and to its amorphous form, to processes for the preparation thereof, to compositions containing the same and their uses for the manufacture of a medicament for the treatment of the human body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.